Antibiotic market to reach US$ 74.07 billion by 2033; FDA approves GSK’s Blujepa for uncomplicated UTIs

Data Compilation
#PharmaFlow

Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

Stock Recap
#PipelineProspector

Controloc

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

164 API Suppliers, 58 USDMF, 49 CEP/COS, 51 EU WC, 19 KDMF, 30 NDC API, 86 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

50 Drugs in Development

50 Drugs in Development

INTERMEDIATES

35 Intermediate Suppliers

35 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

1110 FDF Dossiers, 69 FDA Orange Book, 603 Europe, 41 Canada, 120 Australia, 71 South Africa, 206 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

POWDER;INTRAVENOUS - EQ 40MG BASE/VIAL, TABLET, DELAYED RELEASE;ORAL - EQ 20MG BASE, TABLET, DELAYED RELEASE;ORAL - EQ 40MG BASE, INJECTABLE;INTRAVENOUS - EQ 40MG BASE/VIAL

RELATED EXCIPIENT COMPANIES

1 Minakem, 12 Evonik, 1 Rochem International Inc, 21 SPI Pharma, 7 DKSH, 7 Boai NKY Pharmaceuticals Ltd, 6 Gangwal Healthcare, 8 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 2 Pfanstiehl, 4 Kirsch Pharma, 1 ACG Worldwide, 6 Actylis, 2 Aeon Procare, 2 Alcedo Pharmachem, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 1 Avesta Pharma, 35 BASF, 2 Clariant, 16 Corel Pharma Chem, 6 DFE Pharma, 3 Doshion Polyscience, 1 Esteem Industries, 2 Finar, 13 Gangwal Chemicals, 13 Ideal Cures, 4 Ingredion Pharma Solutions, 26 Kerry, 2 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 14 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 4 Novo Excipients, 5 Pharmatrans-Sanaq, 5 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 21 Roquette, 14 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 3 Silverline Chemicals, 2 The Dow Chemical Company, 2 Ulanqab Kema New Material, 3 Valens Pharmachem, 3 Vasa Pharmachem, 1 Vertellus

EXCIPIENTS BY APPLICATIONS

76 Coating Systems & Additives, 73 Fillers, Diluents & Binders, 46 Direct Compression, 40 Controlled & Modified Release, 38 Disintegrants & Superdisintegrants, 36 Solubilizers, 34 Granulation, 34 Thickeners and Stabilizers, 33 Taste Masking, 25 Film Formers & Plasticizers, 23 Chewable & Orodispersible Aids, 22 Lubricants & Glidants, 21 Topical, 21 Parenteral, 14 Co-Processed Excipients, 10 Emulsifying Agents, 7 Surfactant & Foaming Agents, 6 Rheology Modifiers, 6 API Stability Enhancers, 5 Coloring Agents, 5 Empty Capsules, 4 Vegetarian Capsules

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 63 News #PharmaBuzz

GLOBAL SALES INFORMATION

38 US Medicaid Prescriptions, 408 Regulatory FDF Prices, 10 Annual Reports

MARKET PLACE

71 APIs, 55 FDF Dossiers

PATENTS & EXCLUSIVITIES

8 US Patents, 1 US Exclusivities, 17 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 24 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	Registration No.	Compound	Registration Date	Manufacturer	Manufacturer's Country	Manufacturer's Address
29/11/2025	PMC Isochem	France	Takeda Pharmaceutical Company Korea Co., Ltd.	20220418-209-J-1270	Pantoprazole sodium sesquihydrate	2022-04-18	PMC ISOCHEM	France	4 Rue Marc Sangnier, 45300 PITHIVIERS, France
29/11/2025	Aurobindo Pharma Limited	India	Dong-A ST Co., Ltd.	20210304-209-J-855	Pantoprazole sodium sesquihydrate	2021-03-04	Apitoria Pharma Private Limited	India	Unit-I, Sy.No. 379, 385, 386, 388 - 396, Borpatla Village, Hatnoora Mandal, Sangareddy District, Telangana, 502 296 INDIA

Controloc

Controloc

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

164 API Suppliers

58 USDMF

49 CEP/COS

51 EU WC

19 KDMF

30 NDC API

86 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

50 Drugs in Development

INTERMEDIATES

35 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

1110 FDF Dossiers

69 FDA Orange Book

603 Europe

41 Canada

120 Australia

71 South Africa

206 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

POWDER;INTRAVENOUS - EQ 40MG BASE/VIAL

TABLET, DELAYED RELEASE;ORAL - EQ 20MG BASE

TABLET, DELAYED RELEASE;ORAL - EQ 40MG BASE

INJECTABLE;INTRAVENOUS - EQ 40MG BASE/VIAL

RELATED EXCIPIENT COMPANIES

1 Minakem

12 Evonik

1 Rochem International Inc

21 SPI Pharma

7 DKSH

7 Boai NKY Pharmaceuticals Ltd

6 Gangwal Healthcare

8 Nanjing Well Pharmaceutical

1 Shanghai Minbiotech

2 Pfanstiehl

4 Kirsch Pharma

1 ACG Worldwide

6 Actylis

2 Aeon Procare

2 Alcedo Pharmachem

7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

2 Ashland

1 Avesta Pharma

35 BASF

2 Clariant

16 Corel Pharma Chem

6 DFE Pharma

3 Doshion Polyscience

1 Esteem Industries

2 Finar

13 Gangwal Chemicals

13 Ideal Cures

4 Ingredion Pharma Solutions

26 Kerry

2 Keval Exports

3 Kima Chemical

6 Lonza Capsugel

14 Microlex e.U

1 Nanjing Bold Chemical

2 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

4 Novo Excipients

5 Pharmatrans-Sanaq

5 Pluviaendo

2 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

21 Roquette

14 Seppic

5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

10 Sigachi Industries